Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
DSwiss, Inc. (DQWS)
Kuala Lumpur, MY
DSwiss, Inc. is a biotech-nutraceutical company that supplies a comprehensive range of health and beauty products. Its market reach extends across Malaysia, Singapore, Indonesia, Taiwan, Macau, Hong Kong, and China. The company's product line includes specialized items like DSwiss coffee, targeting digestive well-being, and DSwiss kiwi, formulated to boost the immune system, improve skin tone, help manage blood pressure, and minimize the risk of heart disease and stroke. DSwiss Triple SC focuses on stem cell-related benefits. For skincare, DSwiss offers the DSwiss silk mask, designed for dry, damaged, and sensitive skin; the DSwiss coffee slimming scrub, a natural body exfoliant for removing impurities; the cooling DSwiss peppermint slimming gel; the DSwiss new age essence, which provides nutrients to moisturize, brighten, and refresh tired-looking skin; and the DSwiss enlighten essence cream, a light, nourishing formula. DSwiss also provides medical eyewear under the name DSwiss BioSpec. Its broader health offerings include Genmune-Pro, which strengthens the human immune system by enhancing digestive health; SkinEra, a solution for various skin conditions such as acne, pimples, atopic dermatitis, dry skin, and allergic rashes; SensiBath gel; and SuiSu hand purifiers, sanitizers, and air sanitizers. Specialized supplements include MasterLiv for liver support, MasterHeart for maintaining optimal heart health and smooth blood circulation, and WellG, which delivers essential nutrients for sugar metabolism and energy production. In addition to its product range, DSwiss, Inc. offers diagnostic and analytical equipment. This includes the DSwiss quantum magnetic analyzer, a device that interprets body energy fields to assess health status and offer recommendations, and an AI skin analyzer machine, a facial camera designed to collect skin image data. The company also provides turnkey private label manufacturing services and DNA microarray genotyping services. Furthermore, DSwiss supplies a variety of medical consumables, such as surgical gowns and gloves, 3-ply face masks, N95 masks, protective goggles, body infrared thermometers, disposable bedsheets, and stretcher covers. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -50.59% | +61.54% | +31.25% | +7.69% | -52.27% | -58.00% | -99.53% | -95.23% | -95.23% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Household & Personal Products: +3.3%-6.2% Q1'26: -52.3% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-500.0% Q1'26: -85.7% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-3.6% Q1'26: -11.5% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%-1.6% Q1'26: +2.3% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%— Q1'26: +63.5% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×15.42× Q1'26: 2.12× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ming Chia Leong | Founder, Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer & Director | 101.3K | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DQWS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
